Trump's drug price announcement was a rushed publicity stunt that actually delivered worse deals than existing agreements. The administration quietly released results at 6 p.m. without press events, hiding that negotiated prices were higher than voluntary deals already secured. Medicare beneficiaries got shortchanged with $276 Ozempic versus the $245 price already available.